PPT-XOSPATA TM (gilteritinib)
monotherapy for the treatment of relapsed or refractory acute myeloid leukaemia AML with a FLT3 mutation 1 XOS20200016IL Date of preparation Nov2020 1 MOH approved
Download Presentation
"XOSPATA TM (gilteritinib)" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.